Parvovirus B19-induced type II mixed cryoglobulinemia

Am J Med. 2011 Sep;124(9):e7-8. doi: 10.1016/j.amjmed.2011.02.039.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Disease
  • Antibodies, Viral / blood
  • Antineoplastic Agents / therapeutic use
  • Cryoglobulinemia / diagnosis*
  • Cryoglobulinemia / drug therapy
  • Cryoglobulinemia / virology
  • DNA, Viral / analysis
  • Diagnosis, Differential
  • Glomerulonephritis, Membranoproliferative / diagnosis
  • Glomerulonephritis, Membranoproliferative / drug therapy
  • Glomerulonephritis, Membranoproliferative / virology
  • Humans
  • Lenalidomide
  • Male
  • Middle Aged
  • Parvoviridae Infections / diagnosis*
  • Parvoviridae Infections / drug therapy
  • Parvoviridae Infections / virology
  • Parvovirus B19, Human / genetics
  • Parvovirus B19, Human / immunology
  • Parvovirus B19, Human / pathogenicity*
  • Thalidomide / analogs & derivatives
  • Thalidomide / therapeutic use
  • Viral Load
  • Virulence

Substances

  • Antibodies, Viral
  • Antineoplastic Agents
  • DNA, Viral
  • Thalidomide
  • Lenalidomide